Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Davepark5on Dec 20, 2022 7:00pm
285 Views
Post# 35183505

Bravo Quentin for stating the obvious

Bravo Quentin for stating the obviousfool pumpers contend that anyone who is pissed off about sitting on dead money for so many years must be getting paid by a hedge fund.   Well maybe i need to check my mail box again cause i could sure use some money after being invested in this con job for over 5 years...at no small position either....65000 shares.  Stupidly listened to pumpers like Canada with his "few understand" bs....i wish someone had warned me.  All of these fantastic study results have not produced Jack...the stock price longterm has done nothing the volume is piss.  No one cares about this company except the Kool Aid drinkers on this page and on stocktwits....Foxmf and retardable i have to really wonder about the sanity of these two....Fox really believes he will wake up soon and be worth millions..well if not this year maybe next.....CAnada is way exaggerating the DD these big pharmas are doing on ONCY ---clearly he is a novice to the drug approval process....these companies lend out there drugs to numerous bios working on trials.....its a very common practice and does not suggest anything special about ONCY.....why dont the insiders have large numbers of shares?  why arent the institutions loading up???  Just listen Fox....he knows more thanthe  insiders and the instituions.....
<< Previous
Bullboard Posts
Next >>